Kolibri

📍 Paris, France🗓 Founded 2021👥 12 employees💰 Last funded 2023
Biotechnology🌐 kolibrilab.com
Website LinkedIn
Kolibri revolutionises the way we grow cells at scale using acoustic waves. Showing 100x increase in cell density and 50x reduction in production costs, our patented bioreactors help our partners in drug development unlock patient access to gene therapies. Being cell-agnostic and scalable, our process has significant potential across a range of high-value cell-based therapies - or in the cellular agriculture space more broadly.
1
Total investors
1
Early stage
0
Mid stage
0
Late stage
2021
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
1
Frequently asked questions
Who invested in Kolibri?
Kolibri has 1 investors on record on gritt.io, including 1 early-stage backers.
When did Kolibri last raise funding?
The most recent investment in Kolibri recorded on gritt.io was in 2023.
When was Kolibri founded?
Kolibri was founded in 2021.
What industry is Kolibri in?
Kolibri operates in Biotechnology. Find similar Biotechnology investors on gritt.io.
Where is Kolibri based?
Kolibri is headquartered in Paris, France.